This is particularly evident in myocardial infarction (MI), where PGRN levels correlate positively with the severity of coronary artery disease, suggesting its potential as a biomarker for disease severity; conversely, low baseline PGRN levels may indicate increased susceptibility. This evidence concerns the gene GRN and myocardial infarction.